Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women

Completed · Not applicable

Conditions studied: Cervical Cancer

In brief

The purpose of this trial is to determine whether mailing in-home human papillomavirus (HPV) screening kits is effective in increasing uptake of cervical cancer screening and early detection and treatment of cervical neoplasia in underscreened women.

Key facts

Study ID

NCT02005510

Run by

University of Washington

People needed

19851

Starts

2014-02-01

Expected to finish

2018-02-01

Last updated by the study team

2020-09-16

Who can join

Age: 30 and older, up to 64. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female
• 30 to 64 years of age
• Have a primary care provider at Group Health
• Received annual "birthday letter" with Pap screening reminder 5 months earlier
• No Pap test in the past 3.4 years
• Continuously enrolled at Group Health for at least 3.4 years
• No hysterectomy

You may not qualify if…

• Currently pregnant
• Language interpreter needed
• On "do not contact list" for research studies

Where it is running

• Kaiser Permanente Washington Health Research Institute — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.